WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in DXCM — Dexcom Inc

CIK 1632972 PLYMOUTH, MN

Position in DXCM

as of Mar 31, 2026 · filed Apr 8, 2026 Compact

Position Value

$4,693,044

+$983,692 QoQ

Shares Held

74,730

+33.7% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 5.6736829428215865.ToString("F0")% Shared 0.ToString("F0")% None 94.32631705717841.ToString("F0")%

Healthcare · as of Mar 31, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $292,456,726 across 40 Medical Devices names. DXCM ranks #7 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	1,203,269	$123,539,628
2	MDT	Medtronic plc	763,139	$66,125,994
3	SYK	Stryker Corp	137,419	$45,154,509
4	BSX	Boston Scientific Corp	179,724	$11,277,681
5	EW	Edwards Lifesciences Corp	88,840	$7,114,307
6	ZBH	Zimmer Biomet Holdings, Inc.	68,719	$6,213,571
7	DXCM	Dexcom Inc This page	74,730	$4,693,044
8	STE	STERIS plc	19,537	$4,320,216

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,693,044	74,730	+33.7%	Shares	Sole	2026-04-08
2025-12-31	$3,709,352	55,889	+144.6%	Shares	Sole	2026-01-08
2025-09-30	$1,537,374	22,847	-36.1%	Shares	Sole	2025-10-29
2025-06-30	$3,121,228	35,757	-5.8%	Shares	Sole	2025-07-10
2025-03-31	$2,591,264	37,945	+19.5%	Shares	Sole	2025-04-16
2024-12-31	$2,470,052	31,761	+54.4%	Shares	Sole	2025-03-17
2024-09-30	$1,379,146	20,572	-6.3%	Shares	Sole	2024-10-24
2024-06-30	$2,490,391	21,965	-13.3%	Shares	Sole	2024-07-16
2024-03-31	$3,512,161	25,322	+11.4%	Shares	Sole	2024-04-15
2023-12-31	$2,820,689	22,731	+18.2%	Shares	Sole	2024-01-30
2023-09-30	$1,793,972	19,228	+964.7%	Shares	Sole	2023-11-13
2023-03-31	$209,821	1,806	—	Shares	Sole	2023-04-25
No filing history on record for this holder in this stock.